Combination of MPPa-PDT and HSV1-TK/GCV gene therapy on prostate cancer
Crossref DOI link: https://doi.org/10.1007/s10103-017-2331-6
Published Online: 2018-01-06
Published Print: 2018-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Liang, Liming
Bi, Wenxiang
Chen, Weiwen
Lin, Yani
Tian, Yuanyuan
Funding for this research was provided by:
National Natural Science Foundation of China (81401495, 81372764)
License valid from 2018-01-06